More importantly, the expression of ZO-1 and junctional adhesion molecule A (JAM-A) were reduced in NAFLD patients (Miele et al., 2009; Rahman et al., 2016). This evidence concerns the gene F11R and metabolic dysfunction-associated steatotic liver disease.